About Companion Animal Specialty Drugs
Companion animals are becoming a part of urban population. The factors that have contributed to increased companion animal ownership includes nuclear families and the growing geriatric population living independently. This increasing pet adoption is essentially driving the demand for companion animal specialty drugs, because of the growing prevalence of various diseases and awareness toward pet nutrition.
Technavio’s analysts forecast the global companion animal specialty drugs market to grow at a CAGR of 4.99% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global companion animal specialty drugs market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Companion Animal Specialty Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Bayer
• Elanco
• Merial
• Zoetis
Other prominent vendors
• Aratana therapeutics
• Beaphar
• Henry Schein
• Mars
• The J.M Smucker Company
Market driver
• Increase in Pet humanization
• For a full, detailed list, view our report
Market challenge
• Patent expiry
• For a full, detailed list, view our report
Market trend
• Enhanced product offerings
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
• Market outline
PART 05: OVERVIEW
• One Health Concept
PART 06: MARKET LANDSCAPE
• Market overview
PART 07: MARKET SIZING
• Market size and forecast 2016-2021
PART 08: FIVE FORCES ANALYSIS
PART 09: MARKET SEGMENTATION BY PRODUCT TYPE
• Segmentation by product type
• Comparison by product type
• Global companion animal vaccines market
• Global companion animal antibiotics market
• Global companion animal feed additives market
• Global companion animal parasiticides market
• Global companion animal others drugs market
• Market opportunity by product type
PART 10: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
• Veterinary hospitals
• Pet care clinics
• Pharmacy stores
PART 11: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Companion animal specialty drugs market in Americas
• Companion animal specialty drugs market in EMEA
• Companion animal specialty drugs market in APAC
• Key leading countries
• Market opportunity
PART 12: DECISION FRAMEWORK
PART 13: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 14: MARKET TRENDS
• Enhanced product offerings
• Increase in M&A
• Rising obesity in pets
• PART 15: VENDOR LANDSCAPE
• Vendor landscape
PART 16: VENDOR ANALYSIS
• Vendor overview
• Bayer
• Elanco
• Merial
• Zoetis
PART 17: APPENDIX
• List of abbreviations
List of Exhibits
Exhibit 01: Health hazards in companion animals
Exhibit 02: Global companion animal specialty drugs market by product type
Exhibit 03: Global companion animal specialty drugs market 2016-2021 ($ millions)
Exhibit 04: Global companion animal specialty drugs market: Year-over-year growth 2017-2021 (%)
Exhibit 05: Five forces analysis
Exhibit 06: Global companion animal specialty drugs market by product type 2016-2021 (%)
Exhibit 07: Global companion animal specialty drugs comparison by product type
Exhibit 08: Global companion animal vaccines market 2016-2021 ($ millions)
Exhibit 09: Global companion animal vaccines market: Year-over-year growth 2017-2021 (%)
Exhibit 10: Global companion animal antibiotics market 2016-2021 ($ millions)
Exhibit 11: Global companion animal antibiotics market: Year-over-year growth 2017-2021 (%)
Exhibit 12: Global companion animal feed additives market 2016-2021 ($ millions)
Exhibit 13: Global companion animal feed additives market: Year-over-year growth 2017-2021 (%)
Exhibit 14: Global companion animal parasiticides market 2016-2021 ($ millions)
Exhibit 15: Global companion animal parasiticides market: Year-over-year growth 2017-2021 (%)
Exhibit 16: Global companion animal others market 2016-2021 ($ millions)
Exhibit 17: Global companion animal others market: Year-over-year growth 2017-2021 (%)
Exhibit 18: Market opportunity by product type
Exhibit 19: Global companion animal specialty drugs by geography 2016-2021 (% share)
Exhibit 20: Regional comparison
Exhibit 21: Companion animal specialty drugs market in Americas 2016-2021 ($ millions)
Exhibit 22: Companion animal specialty drugs market in Americas: Year-over-year growth 2017-2021
Exhibit 23: Companion animal specialty drugs market in EMEA 2016-2021 ($ millions)
Exhibit 24: Companion animal specialty drugs market in EMEA: Year-over-year growth 2017-2021
Exhibit 25: Companion animal specialty drugs market in APAC 2016-2021 ($ millions)
Exhibit 26: Companion animal specialty drugs market in APAC: Year-over-year growth 2017-2021
Exhibit 27: Key leading countries
Exhibit 28: Bayer: Key highlights
Exhibit 29: Bayer: Strength assessment
Exhibit 30: Bayer: Strategy assessment
Exhibit 31: Bayer: Opportunity assessment
Exhibit 32: Elanco Pharmaceuticals: Key highlights
Exhibit 33: Elanco: Strength assessment
Exhibit 34: Elanco: Strategy assessment
Exhibit 35: Elanco: Opportunity assessment
Exhibit 36: Merial: Key highlights
Exhibit 37: Merial: Strength assessment
Exhibit 38: Merial: Strategy assessment
Exhibit 39: Merial: Opportunity assessment
Exhibit 40: Zoetis: Key highlights
Exhibit 41: Zoetis: Strength assessment
Exhibit 42: Zoetis: Strategy assessment
Exhibit 43: Zoetis: Opportunity assessment
